JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boje, K. M. K.
Right arrow Articles by Raybon, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boje, K. M. K.
Right arrow Articles by Raybon, J. J.

Vol. 304, Issue 1, 319-325, January 2003

Neuroinflammatory Role of Prostaglandins during Experimental Meningitis: Evidence Suggestive of an in Vivo Relationship between Nitric Oxide and Prostaglandins

Kathleen M. K. Boje, David Jaworowicz, Jr.1 and Joseph J. Raybon

Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, New York

Nitric oxide (NO) and prostaglandins are inflammatory mediators produced during meningitis. The purpose of the present study was to pharmacologically inhibit cyclooxygenase-2 (COX-2) and inducible NO synthase (iNOS) to 1) explore the prostaglandin contribution to blood-cerebrospinal fluid barrier permeability alterations and 2) elucidate the in vivo concentration relationship between prostaglandin E2 (PGE2) and NO during experimental meningitis. Intracisternal injection of lipopolysaccharides (LPSs, 200 µg) induced neuroinflammation. Rats were dosed with nimesulide (COX-2 inhibitor), aminoguanidine (iNOS inhibitor), or vehicle. Evans blue was used to assess blood-cerebrospinal fluid barrier permeability. Meningeal NO and cerebrospinal fluid PGE2 were assayed using conventional methods. (Results are expressed as mean ± S.E.M. of 5-9 rats/group.) Nimesulide failed to prevent blood-cerebrospinal fluid barrier disruption [cerebrospinal fluid Evans blue (micrograms per milliliter): control, 0.22 ± 0.22*; LPS, 11.58 ± 0.66; LPS + nimesulide, 10.58 ± 0.86; *p < 0.05; ANOVA]. Although nimesulide decreased PGE2 (picograms per microliter; p < 0.01) in LPS + nimesulide rats (13.9 ± 1.96) versus LPS + vehicle (73.8 ± 12.4), meningeal NO production (picomoles/30 min/106 cells; p < 0.01) increased unexpectedly in LPS + nimesulide rats (439 ± 47) versus LPS + vehicle rats (211 ± 31). In contrast, aminoguanidine inhibited meningeal NO (picomoles/30 min/106 cells; p < 0.005) in LPS + aminoguanidine (111 ± 20) versus LPS (337 ± 48) but had no effects (p > 0.05) on PGE2. The in vivo relationship between PGE2 and NO was mathematically described by a biphasic, bell-shaped curve (r2 = 0.42; n = 27 rats; p < 0.0001). Based on these results, inhibition of prostaglandin synthesis not only fails to prevent blood-cerebrospinal fluid barrier disruption during neuroinflammation and but also promotes increased meningeal NO production. The in vivo concentration relationship between PGE2 and NO is biphasic, suggesting that inhibition of COX-2 alone may promote NO toxicity through enhanced NO synthesis.


1 Current address: Cognigen Corporation, Buffalo, NY 14221.


0022-3565/03/3041-0319$07.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2003 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
J. T. Borda, X. Alvarez, M. Mohan, M. S. Ratterree, K. Phillippi-Falkenstein, A. A. Lackner, and B. A. Bunnell
Clinical and Immunopathologic Alterations in Rhesus Macaques Affected with Globoid Cell Leukodystrophy
Am. J. Pathol., January 1, 2008; 172(1): 98 - 111.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
B. A. Berkowitz, R. Roberts, H. Luan, J. Peysakhov, D. L. Knoerzer, J. R. Connor, and T. C. Hohman
Drug Intervention Can Correct Subnormal Retinal Oxygenation Response in Experimental Diabetic Retinopathy
Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2954 - 2960.
[Abstract] [Full Text] [PDF]


Home page
Journal of Pharmacy PracticeHome page
M. R. Haase
Acute Bacterial Meningitis in Children
Journal of Pharmacy Practice, December 1, 2004; 17(6): 392 - 406.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. Uno, Y. Iuchi, J. Fujii, H. Sugata, K. Iijima, K. Kato, T. Shimosegawa, and T. Yoshimura
In Vivo Study on Cross Talk between Inducible Nitric-Oxide Synthase and Cyclooxygenase in Rat Gastric Mucosa: Effect of Cyclooxygenase Activity on Nitric Oxide Production
J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 995 - 1002.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. Sanchez-Moreno, M. P. Cano, B. de Ancos, L. Plaza, B. Olmedilla, F. Granado, and A. Martin
High-Pressurized Orange Juice Consumption Affects Plasma Vitamin C, Antioxidative Status and Inflammatory Markers in Healthy Humans
J. Nutr., July 1, 2003; 133(7): 2204 - 2209.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.